DUBLIN--(BUSINESS WIRE)--0The "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The breast reconstruction market is expected to reach 603.8 million by 2025 from USD 430.8 million in 2020, at a CAGR of 7.0%.
Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements. However, clinical risks and complications associated with breast reconstruction restrain market growth.
The acellular dermal matrix segment is anticipated to grow at the fastest growth rate during the forecast period.
The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix. The acellular dermal matrix segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the rising incidences of breast cancer, increasing number of mastectomies, and growing use usage of acellular dermal matrices.
The immediate procedure segment is estimated to grow at a rapid rate during the forecast period.
On the basis of procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period. Factors such as the increasing number of surgeries post-mastectomy and rising awareness are driving the market.
Asia Pacific is estimated to register the highest CAGR during the study period.
Geographically, the breast reconstruction market is dominated by North America and Europe. However, the Asia Pacific market is estimated to grow at the fastest rate during the forecast period.
- Rising Incidence of Breast Cancer
- Increasing Awareness
- Reimbursements for Breast Reconstruction
- Clinical Risks and Complications of Breast Reconstruction Procedures
- Alternative Non-Surgical Methods
- Growth Opportunities in Emerging Markets
- Development of 3D-Printed Implants
- Product Failures and Recalls
- Johnson & Johnson
- Polytech Health & Aesthetics
- GC Aesthetics
- Ideal Implant Incorporated
- Establishment Labs S.a.
- Integra Lifesciences
- Laboratories Arion
- Guangzhou Wanhe Plastic Materials
- RTI Surgical Holdings
- Shanghai Kangning Medical Device
- PMT Corporation
For more information about this report visit https://www.researchandmarkets.com/r/yzazwp